Clinical trials
Relatives clinical trials
Below are recruiting relatives clinical trials, each written for real people, not researchers. We’re tracking 2,022 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05152823Enrolling by invitationPhase 1/Phase 2
Gene therapy for IGHMBP2-related nerve conditions
This early-phase study tests a gene therapy meant to treat people who have IGHMBP2 gene changes. It aims to improve the way the nervous system works and to see if the treatment is safe, especially in young children.
Columbus, OhioAges 2 months–14 years - NCT04871932Recruiting
Study of immune response to a COVID-19 vaccine
This trial studies how your immune system responds after a COVID-19 vaccine. It uses detailed blood tests to understand what changes happen in your immune cells and may help researchers improve future vaccines.
ShanghaiAges 18–50 - NCT05080569RecruitingPhase 4
Extra support after IUI for couples with unclear infertility
This study tests whether adding support in the period after ovulation (the “luteal phase”) helps people who are starting IUI (intrauterine insemination) because their infertility is unexplained. It’s designed to see if the added care improves chances when mild ovarian stimulation is used.
UtrechtAges 18 years+ - NCT05054829Recruiting
Social skills group for adults with autism
This trial tests whether a structured social skills training group can improve relationships for adults on the autism spectrum. It may help you practice real-life social situations with guided group support.
TaipeiAges 18–45 - NCT04782752Recruiting
Radiation before lung transplant to help stop lung cancer spread
This study tests a focused, low-dose type of radiation given before a lung transplant. The goal is to help your immune system recognize and attack cancer cells (called “radiovaccination”) and improve outcomes for people who cannot get curative treatment with surgery or SBRT alone.
Toronto, OntarioAges 18 years+ - NCT04840355Recruiting
Monitoring safety of sintilimab in Chinese patients
This study carefully tracks how safe sintilimab is for people with cancer in real-world care. It may help your care team understand side effects and risks during treatment.
Beijing, Beijing MunicipalityAges 18–75 - NCT05256745RecruitingPhase 1/Phase 2
A medicine to protect the heart during breast cancer chemotherapy
This early-phase study tests azeliragon to lower the risk of chemotherapy-related heart damage in women with early-stage breast cancer. Participants get their planned standard chemotherapy, plus the study medicine, and are monitored for safety and heart health.
Washington D.C., District of ColumbiaAges 18 years+ - NCT04797143Recruiting
Program to help people take oral cancer medicines as prescribed
This trial studies whether a team-based clinic visit program can improve how well people stick to their oral (by mouth) cancer medicines. It may help by offering extra support at the start of treatment or after a cancer comes back.
AmiensAges 18 years+ - NCT05233150Recruiting
Parent–child coaching in primary care for young children
This study tests a parent–child relationship coaching program delivered through primary care. It may help families improve day-to-day interactions and child behavior using group sessions and virtual support.
Chapel Hill, North CarolinaAges 1.5 years–99 years - NCT05124132Enrolling by invitation
Study of resilience and brain health after an earlier parent study
This trial looks at how resilience (how well people cope with stress) and brain health change over time in older adults who already joined an earlier study. You may be eligible if you participated in that “parent study.”
St Louis, MissouriAges 65 years+ - NCT04942717Recruiting
Talking about health values with Spanish or English-speaking patients
This study tests an approach for discussing and sharing what patients value about their health, and adapting it for Latinx communities. It involves separate interviews with patients, families/caregivers, and oncology clinicians to improve how the intervention works and is understood.
New York, New YorkAges 21 years+ - NCT04985487Recruiting
Safety follow-up for brolucizumab in neovascular AMD
This study tracks the real-world safety of brolucizumab in adults with neovascular age-related macular degeneration (nAMD). If you’re already prescribed this medicine, the study may help confirm it continues to be safe and well-tolerated over time.
Daegu, Dalseo GuAges 18–100 - NCT07104240Recruiting
Improving HPV vaccination for preteens ages 9-12
This study tests a program designed to help primary care practices increase HPV vaccination rates among adolescents aged 9 to 12 who haven't yet been vaccinated. It aims to find out if providing practices with resources and support can lead to more kids getting the HPV vaccine.
Atlanta, GeorgiaAges 9 years+ - NCT05421416RecruitingPhase 2
Loratadine to prevent bone pain after stem cell transplant treatment
This trial tests loratadine (an allergy medicine) to see if it can prevent bone pain caused by a growth-factor injection used during lymphoma or multiple myeloma treatment. It may help reduce pain around the time you get that injection and your upcoming stem cell transplant.
Edmonton, AlbertaAges 18 years+ - NCT03925311Recruiting
Checking how the uterus is prepared for pregnancy
This study looks at patterns in the uterus and the uterine lining to understand how ready the uterus is for pregnancy. You may be able to join if you are within a specific age range and don’t have certain common uterine conditions.
Hong KongAges 20–40 - NCT03303716Recruiting
Study of the health history of people with ASXL disorders
This study looks at your medical history and health changes over time in people diagnosed with an ASXL-related disorder. It may help researchers better understand how these conditions progress and what needs to be measured in future treatments.
Los Angeles, CaliforniaAges Any age - NCT03001921Recruiting
Practice add-on for people on hemodialysis
This trial is for people with end-stage kidney disease who are already receiving hemodialysis. It tests a “wise practice” program or approach during dialysis to see if it can help patients in some meaningful way.
Guangzhou, GuangdongAges 18 years+ - NCT02918032Recruiting
Registry study for triglyceride storage heart and blood vessel disease
This is a registry study that collects health information from people diagnosed with neutral lipid storage disease (NLSD) or triglyceride deposit cardiomyovasculopathy (TGCV). It may help researchers better understand the condition and improve future care plans.
Stanford, CaliforniaAges Any age - NCT05588245Recruiting
Community support to help pregnant people during prenatal care
This study tests a community-based support program (“patient navigation”) to help pregnant people with unmet social needs get the care they need. It includes support from early pregnancy through 12 months after delivery and may help if social needs are affecting your prenatal care.
Atlanta, GeorgiaAges 18 years+ - NCT05053113Recruiting
Text-and-Fitbit support for less-active women to move more
This trial studies a peer-based (partner) approach using text messages and a Fitbit app to help inactive women increase their physical activity. It may help you find easier, ongoing motivation and support to reach recommended activity levels.
Houston, TexasAges 18–65 - NCT04988074RecruitingPhase 2
Test cemiplimab for HPV-positive throat cancer using tumor biomarkers
This Phase 2 trial studies whether cemiplimab (with or without chemotherapy first) can improve treatment for HPV-positive oropharynx throat cancer. It also uses lab “biomarkers” to help guide which treatment you get next.
Baltimore, MarylandAges 18 years+ - NCT05121051RecruitingPhase 2
Broccoli sprout extract to reduce tobacco cancer-causing chemicals
This Phase 2 study tests whether broccoli sprout extract (Avmacol ES) can reduce cancer-causing substances linked to heavy smoking. It’s for adults who smoke heavily and may help lower harmful tobacco-related chemical effects in the body.
Tucson, ArizonaAges 18 years+ - NCT05136950Recruiting
Tracking side effects after secondary lens surgery for cataracts
This study follows children who had congenital cataract surgery to see how often glaucoma-related side effects happen after getting a secondary intraocular lens. It may help doctors better prevent and catch eye pressure problems after these surgeries.
GuangzhouAges 1.5 years–14 years - NCT04237623RecruitingPhase 2
GM-CSF after transplant using a matched related donor
This Phase 2 study tests whether giving a medicine called GM-CSF after an allogeneic transplant (using a matched related donor) can improve outcomes. Participants must meet health and donor-matching requirements and be eligible to safely receive the treatment and consent to the study.
Atlanta, GeorgiaAges 18–78
Hear when a new Relatives trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for relatives?
- Yes. Clin2 currently lists 2,022 recruiting relatives studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a relatives trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a relatives trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.